InvestorsHub Logo

MUKA1

10/24/13 9:21 PM

#87888 RE: zoomboom #87883

Lol! Agree. #5 has my vote as well. Already has MJFF vote.....

zoomboom

01/06/14 7:34 PM

#91347 RE: zoomboom #87883

the already have the Phase II candidate ..

Amarantus Seeks Candidate For PD-LID

On May 22, 2013, Amarantus entered into a letter of intent to in-license a phase 2 drug candidate in L-Dopa-Induced Dyskinesia (LID) in patients with Parkinson's Disease from an undisclosed third party. Once the license is complete, Amarantus plans to initiate a phase 2b trial within 12 months.